Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118832652 | 11883265 | 2 | F | 20141219 | 20160801 | 20151231 | 20160804 | PER | US-CELGENEUS-USA-2015010970 | CELGENE | 66.02 | YR | F | Y | 56.75000 | KG | 20160804 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118832652 | 11883265 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | UNKNOWN | 21880 | 25 | MG | CAPSULES | |||||
| 118832652 | 11883265 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | UNKNOWN | 21880 | 15 | MG | CAPSULES | |||||
| 118832652 | 11883265 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | U | UNKNOWN | 21880 | 8 | MG | UNKNOWN | /wk | ||||
| 118832652 | 11883265 | 4 | C | ARIXTRA | FONDAPARINUX SODIUM | 1 | Unknown | 8 MILLIGRAM | 0 | UNKNOWN | |||||||||
| 118832652 | 11883265 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 118832652 | 11883265 | 6 | C | MUCINEX | GUAIFENESIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 118832652 | 11883265 | 7 | C | DYAZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 118832652 | 11883265 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 118832652 | 11883265 | 9 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 118832652 | 11883265 | 10 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118832652 | 11883265 | 1 | Plasma cell myeloma |
| 118832652 | 11883265 | 3 | Plasma cell myeloma |
| 118832652 | 11883265 | 4 | Product used for unknown indication |
| 118832652 | 11883265 | 5 | Product used for unknown indication |
| 118832652 | 11883265 | 6 | Product used for unknown indication |
| 118832652 | 11883265 | 7 | Product used for unknown indication |
| 118832652 | 11883265 | 8 | Product used for unknown indication |
| 118832652 | 11883265 | 9 | Product used for unknown indication |
| 118832652 | 11883265 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118832652 | 11883265 | HO |
| 118832652 | 11883265 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118832652 | 11883265 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118832652 | 11883265 | 1 | 20101001 | 20111012 | 0 | |
| 118832652 | 11883265 | 2 | 20111205 | 0 | ||
| 118832652 | 11883265 | 3 | 20120913 | 0 |